Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 1,995.90
+52.55 (2.70%)
At close: Jan 22, 2026
Glenmark Pharmaceuticals Employees
Glenmark Pharmaceuticals had 15,800 employees as of March 31, 2025. The number of employees increased by 811 or 5.41% compared to the previous year.
Employees
15,800
Change (1Y)
811
Growth (1Y)
5.41%
Revenue / Employee
10.12M INR
Profits / Employee
639.14K INR
Market Cap
563.61B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 15,800 | 811 | 5.41% |
| Mar 31, 2024 | 14,989 | -567 | -3.64% |
| Mar 31, 2023 | 15,556 | 141 | 0.91% |
| Mar 31, 2022 | 15,415 | 4,451 | 40.60% |
| Mar 31, 2021 | 10,964 | 297 | 2.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,811 |
| Lupin | 24,006 |
| Torrent Pharmaceuticals | 17,059 |
| Jubilant Pharmova | 5,547 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,659 |
Glenmark Pharmaceuticals News
- 3 days ago - Pharma sector stocks fall today: Glenmark Pharma drops 1.38%, Aurobindo Pharma downm 1.25%, Sun Pharma falls 0.87, Dr. Reddy’s Lab down 0.48% - Business Upturn
- 9 days ago - Pharma sector stocks today: Sun Pharma falls 1.20%, Lupin down 1%, Glenmark Pharma rises 0.49% - Business Upturn
- 10 days ago - Pharma sector stocks today: Glenmark Pharma falls 2.41%, Dr Reddy’s Laboratories down 1.39%, Emcure up 1.70% - Business Upturn
- 4 weeks ago - Glenmark Pharma launches Epinephrine Injection USP multiple-dose vial in the US - Business Upturn
- 5 weeks ago - Top stocks to watch today, December 17: Ola Electric, NBCC, Ahluwalia Contracts, Glenmark Pharma, BEML and more - Business Upturn
- 5 weeks ago - Glenmark Pharma enters licensing deal with Hansoh Pharma for lung cancer drug aumolertinib - Business Upturn
- 6 weeks ago - Glenmark Pharma to launch Leucovorin Calcium for Injection USP, 350 mg/vial in the U.S. market - Business Upturn
- 7 weeks ago - Glenmark’s Aurangabad Facility Clears US FDA Inspection With Zero Observations - Business Upturn